VitalSpec VitalSpec
Home Compliance

— Markets Intelligence

Intelligence for critical industry.

VitalSpec publishes open-source intelligence assessments on the industrial systems critical industry runs on — who makes what, where the bottlenecks sit, and where capacity must be built. Every assessment is built the same way: key judgements with confidence levels, every claim source-linked, assumptions stated and stress-tested.

Our first series examines the defence industrial base; industrial outlooks for other critical sectors will follow. Executive summaries are free to read below. Full reports — with complete source registers and quarterly indicator updates — download in exchange for a work email.

Flagship · Outlook Paper 01

Defence Industrial Outlook 2026

Why explosive fill, propellant and LAP will define Europe’s rearmament

July 2026 · 33 pages · 77-source linked register · Public-source analysis

Executive summary

Europe is spending on rearmament at treaty level. It cannot yet manufacture what the money buys. The Outlook is a public-source intelligence assessment of the industrial system behind Europe’s 155 mm ammunition rebuild — and its findings are uncomfortable, quantified, and directly relevant to anyone deciding where the next wave of capacity gets built.

The bottleneck has moved. Shell-body and assembly capacity is scaling fast — Europe’s largest new plant went from ground-break to opening in 15 months. The constraint is now high-explosive fill, propellant, and the loading, assembly and packing capacity that turns components into certified rounds. A warehouse of inert bodies is not firepower.

The TNT window is real and dated. Europe’s dominant TNT producer has committed 18,000 tonnes to the US market across 2027–2029 — exactly the years allied intelligence services identify as the period in which Russia could reconstitute the capability to threaten NATO.

The finding survives any stockpile assumption. We derive Europe’s requirement three independent ways. Even the most conservative floor — roughly 30 million rounds — absorbs about 18 years of Europe’s generously-estimated RDX output. Readers do not have to accept our strategic insurance tiers for the conclusion to hold.

Demand survives a ceasefire. The structural deficits — energetics and LAP — persist under treaty-anchored NATO capability targets and contracted replenishment. The downside case is modelled, not waved away.

Market Intelligence 02

Global Bodies, Foundries & Freight

The 155 mm projectile-body trade: who forges, who buys, and why freight sets the corridor economics

July 2026 · Built on VitalSpec proprietary intelligence holdings: 172 foundry entries, 84 manufacturers, 280 supply pairings, 16 priced freight lanes

Executive summary

The body problem is solvable through trade. The freight problem is where the margin lives.

Bodies are abundant globally, scarce inside Europe. European lines are scaling fast but remain committed to national programmes, while the US — targeting 100,000 rounds a month and producing about 40,000 — absorbs its own output. Western filling capacity outgrows local body supply through at least 2028.

The India corridor is proven, not theoretical. Tens of millions of dollars of empty casings have already shipped to European buyers, at forge-direct prices one-third to one-half of European body cost. The buy-empty, fill-in-Europe model is operating today.

Freight is a staircase, not a curve. Mainline carriers bucket even inert bodies as military cargo, pushing the trade onto voyage-priced multipurpose tonnage: roughly $145 per body at pilot lots falling to roughly $58 at full 50-container parcels on the same sailing. The operator who aggregates demand to fill parcels captures a per-body advantage larger than most forge-to-forge price differences.

Second-tier supply bases are one qualification away. ASEAN, Türkiye and Latin American foundries have the metallurgy; what they lack is NATO-standard qualification and batch proof. Whoever builds that bridge first owns it.

Market Intelligence 03

The Commodity Chain

From ammonia and cotton to finished rounds: the precursor supply chains that decide whether Europe’s ammunition plants can actually run

July 2026 · Public-source analysis · Material-by-material dependency matrix

Executive summary

Europe is financing the visible layer of its rearmament and importing the invisible one. Every new energetics plant announced since 2022 assumes its feedstocks will be there when it opens. MI-03 traces every kilogram of a 155 mm round back to its trunk precursors — and finds a chain that repeatedly narrows to one country or one company.

Nitrocellulose feedstock is the acute dependency. More than 70% of the cotton linters behind military nitrocellulose come from China, which restricted exports in 2024. Military demand of around 20,000 tonnes a year faces a shortfall estimated at up to 10,000 tonnes, and no mitigation closes the gap before about 2030.

Nitroguanidine is a one-company Western market. A single German producer supplies the West; the US Department of Defense has committed $150m to build it an American plant — official money pricing a single-source risk. The insensitive-munitions transition increases this exposure.

The acid backbone is the cheapest insurance nobody is buying. Every nitration step rides on nitric and sulphuric acid from a European fertiliser industry that has been shedding capacity for a decade. Co-located acid supply and recovery is a small-capex, high-leverage gap.

Precursor positions are mispriced. Tens of millions of capex can gate hundreds of thousands of rounds a year. Governments have started paying for this insurance; private capital largely has not.

— Coming soon

VitalSpec Markets

The living data behind these reports — entity and facility mapping, capabilities, certifications, licences and supply-chain connections across the defence industrial base — is being built into a member-access intelligence platform at markets.vitalspec.co. Report subscribers receive early access.

— Markets Intelligence

Download the full report

Company addresses only — personal email domains are not accepted.

Your details are used to deliver the report and for a possible follow-up from our team — nothing else.

If the download didn’t start, click here.

VitalSpec VitalSpec

Discreet. Reliable. Effective.

A supply-chain partner for critical industry.

Home Compliance LinkedIn ✉  ENQUIRE PRIVATELY

© 2026 VitalSpec Limited · Registered in England & Wales, Company No. 17261610 · London, United Kingdom